Sarepta Therapeutics, Inc. (SRPT) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Sarepta (SRPT) Q4 2025: $193M Inventory Charge Resets Margin Structure as Gene Therapy Messaging Overhaul Begins
June 15, 2026
-
Sarepta Therapeutics (SRPT) Q1 2026: $325M Roche Decline Drives Cash Strength as Gene Therapy Initiatives Scale
May 07, 2026
-
SRPT Q3 2025: $300M Expense Cut Reshapes Pipeline Focus as PMO Data Faces FDA Scrutiny
November 04, 2025
-
Sarepta Therapeutics (SRPT) Q1 2025: Alevitus Revenue Jumps 180% but Guidance Cut on Cycle Delays
July 07, 2025